Sheldon Sloan
Chief Medical Officer · 2 filings · Latest: May 1, 2026
Spyre Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
SYRE | Sheldon Sloan | Chief Medical Officer | May 1, 2026 | Sale | $71.50 | 78,333 | $5.6M | 0 | |
SYRE | Sheldon Sloan | Chief Medical Officer | May 1, 2026 | Option Exercise | $27.46 | 78,333 | $2.2M | 78,333 | |
SYRE | SHELDON SLOAN | — | May 1, 2026 | Proposed Sale | $74.45 | 78,333 | $5.8M | — | |
SYRE | Sheldon Sloan | Chief Medical Officer | Apr 1, 2026 | Sale | $50.00 | 7,958 | $397.9K | 0 | |
SYRE | Sheldon Sloan | Chief Medical Officer | Apr 1, 2026 | Option Exercise | $21.66 | 7,958 | $172.4K | 7,958 | |
SYRE | SHELDON SLOAN | — | Apr 1, 2026 | Proposed Sale | $50.44 | 7,958 | $401.4K | — |